Evidence map›Paper›PMID 27244559›Full record

ArticlePloS one2016

Modeling Effects of RNA on Capsid Assembly Pathways via Coarse-Grained Stochastic Simulation.

Gregory R Smith, Lu Xie, Russell Schwartz

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gregory R SmithDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.
Lu XieJoint Carnegie Mellon/University of Pittsburgh Ph.D. Program in Computational Biology, Pittsburgh, Pennsylvania, United States of America.
Russell SchwartzDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.

Funding

Heterogeneous Cancer Progression from Microarray DataR01CA140214 · NCI · CARNEGIE-MELLON UNIVERSITY · PI SCHWARTZ, RUSSELL S · 2009 to 2013
$1.4M
Inferring in vivo Capsid Assembly Kinetics from in vitro by Stochastic SimulationR01AI076318 · NIAID · CARNEGIE-MELLON UNIVERSITY · PI SCHWARTZ, RUSSELL S · 2009 to 2012
$1.1M
NCI NIH HHS R01 CA140214NIAID NIH HHS R01 AI076318
6 · The paper itself

Abstract

The environment of a living cell is vastly different from that of an in vitro reaction system, an issue that presents great challenges to the use of in vitro models, or computer simulations based on them, for understanding biochemistry in vivo. Virus capsids make an excellent model system for such questions because they typically have few distinct components, making them amenable to in vitro and modeling studies, yet their assembly can involve complex networks of possible reactions that cannot be resolved in detail by any current experimental technology. We previously fit kinetic simulation parameters to bulk in vitro assembly data to yield a close match between simulated and real data, and then used the simulations to study features of assembly that cannot be monitored experimentally. The present work seeks to project how assembly in these simulations fit to in vitro data would be altered by computationally adding features of the cellular environment to the system, specifically the presence of nucleic acid about which many capsids assemble. The major challenge of such work is computational: simulating fine-scale assembly pathways on the scale and in the parameter domains of real viruses is far too computationally costly to allow for explicit models of nucleic acid interaction. We bypass that limitation by applying analytical models of nucleic acid effects to adjust kinetic rate parameters learned from in vitro data to see how these adjustments, singly or in combination, might affect fine-scale assembly progress. The resulting simulations exhibit surprising behavioral complexity, with distinct effects often acting synergistically to drive efficient assembly and alter pathways relative to the in vitro model. The work demonstrates how computer simulations can help us understand how assembly might differ between the in vitro and in vivo environments and what features of the cellular environment account for these differences.

Indexed as

BromovirusCapsidCapsid ProteinsComputer SimulationHepatitis B virusModels, BiologicalModels, MolecularPapillomaviridaeRNA, ViralVirus AssemblyCapsid ProteinsRNA, Viral

Identifiers

PMID27244559
PMCPMC4887116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.